ConductScience.org, home

Gene · 419

ART3: ADP-ribosyltransferase 3 (inactive)

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ART3: ADP-ribosyltransferase 3 (inactive). Genes, record 419. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/419

On this page

Gene

Symbol
ART3
HGNC
Name
ADP-ribosyltransferase 3 (inactive)
HGNC
NCBI Gene ID
419
NCBI Gene
HGNC ID
HGNC:725
HGNC
Ensembl
ENSG00000156219
NCBI Gene
Aliases
ARTC3
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q13508Ecto-ADP-ribosyltransferase 33890Ensembl, GeneID, HGNC

Source UniProt

Patents25

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1436824Q13508Espacenet
EP 4650780 A22025-11-197212Q13508Espacenet
EP 4641201 A22025-10-297147Q13508Espacenet
JP 2025147176 A2025-10-061122Q13508Espacenet
JP 2025529142 A2025-09-04456Q13508Espacenet
JP 2025529142 A2025-09-045530Q13508Espacenet
US 12371689 B22025-07-29456Q13508Espacenet
US 12371689 B22025-07-295530Q13508Espacenet
JP 2025517969 A2025-06-127147Q13508Espacenet
JP 2025517970 A2025-06-127212Q13508Espacenet

1 to 10 of 25

See all 25 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants370

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleART3 papersNewest fiscal year
R01DK069710The Role of Nuclear PARPs in Signal-Regulated Transcription72025
R01CA214872Parp Function in Prostate Cancer62025
ZIAHL000659ADP-ribosylation Cycles52025
P01AG047200Comparative genomics of longevity and Alzheimer's disease42025
R01CA244417The role of PARP10 in alleviating replication stress and promoting cellular proliferation and tumorigenesis42025
R01ES026184The Role of Mono-ADP-Ribosylation by PARP14 in Radioresistance42025
T32CA009110Training in Areas Fundamental to Cancer Research32025
ZIAAG000295Immobilized Proteins In Drug Discovery32025
ZICES102445Gene Expression and Microarrays32025
P30CA016672Cancer Center Support Grant22025

1 to 10 of 370Source NIH's project files

See all 370 nih grants

Papers560

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
PARP7 drives angiotensin II-induced vascular remodeling via ADP-ribosylation and inhibition of GPX4.Biochim Biophys Acta Mol Basis Dis202642785485PubTator, text miningPubMed
The ADP-ribosyltransferases 3 (ART3) is a novel suppressor of pathological cardiac hypertrophy by ribosylating ITGA7.Acta Pharm Sin B202642765066PubTator, text miningPubMed
Decoding context-dependent sirtuin pharmacology in cancer: Metabolic-epigenetic switches and precision therapeutic targeting.Crit Rev Oncol Hematol202642543141PubTator, text miningPubMed
Plasma proteomics based on machine learning predict the early risk of kidney outcomes in patients with DKD: a prospective cohort study from UK Biobank.Front Nephrol202642445298PubTator, text miningPubMed
Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.Skelet Muscle202642443978PubTator, text miningPubMed
Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.Res Sq202642370242PubTator, text miningPubMed
Transition-state analysis of the arginine-specific human ADP-ribosyltransferase 1.Proc Natl Acad Sci U S A202642201951PubTator, text miningPubMed
PARP14 as a master regulator of immune signaling and tumor microenvironment remodeling.Biochem Pharmacol202642034313PubTator, text miningPubMed
Roles of ADP-Ribosyltransferases in Cancer.Oncol Res202641930181PubTator, text miningPubMed
CancerHubs Data Explorer: a web application for investigating mutation-enriched protein interaction hubs in human cancers.BioData Min202641913220PubTator, text miningPubMed

1 to 10 of 560

See all 560 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/419

GET https://conductscience.org/api/genes/v1/419/patents?page=2